Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.

MLA

Jiayi Wu, et al. “Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer.” PLoS ONE, vol. 9, no. 8, Jan. 2014, p. e98673. EBSCOhost, https://doi.org/10.1371/journal.pone.0098673.

APA

Jiayi Wu, Yu Zong, Xiaochun Fei, Xiaosong Chen, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen, & Li Zhu. (2014). Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer. PLoS ONE, 9(8), e98673. https://doi.org/10.1371/journal.pone.0098673

Chicago

Jiayi Wu, Yu Zong, Xiaochun Fei, Xiaosong Chen, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen, and Li Zhu. 2014. “Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer.” PLoS ONE 9 (8): e98673. doi:10.1371/journal.pone.0098673.